The impact of information about different absolute benefits and harms on intention to participate in colorectal cancer screening: A think-aloud study and online randomised experiment

被引:14
作者
Usher-Smith, Juliet A. [1 ]
Mills, Katie M. [1 ]
Riedinger, Christiane [1 ]
Saunders, Catherine L. [1 ]
Helsingen, Lise M. [2 ,3 ]
Lytvyn, Lyubov [4 ]
Buskermolen, Maaike [5 ]
Lansdorp-Vogelaar, Iris [5 ]
Bretthauer, Michael [2 ,3 ]
Guyatt, Gordon [4 ]
Griffin, Simon J. [1 ]
机构
[1] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England
[2] Univ Oslo, Oslo Univ Hosp, Clin Effectiveness Res Grp, Dept Transplantat Med, Oslo, Norway
[3] Univ Oslo, Inst Hlth & Soc, Oslo, Norway
[4] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[5] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands
来源
PLOS ONE | 2021年 / 16卷 / 02期
关键词
RISK COMMUNICATION; DECISION-MAKING; INFORMED CHOICE; PREFERENCES; FORMATS;
D O I
10.1371/journal.pone.0246991
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background There is considerable heterogeneity in individuals' risk of disease and thus the absolute benefits and harms of population-wide screening programmes. Using colorectal cancer (CRC) screening as an exemplar, we explored how people make decisions about screening when presented with information about absolute benefits and harms, and how those preferences vary with baseline risk, between screening tests and between individuals. Method We conducted two linked studies with members of the public: a think-aloud study exploring decision making in-depth and an online randomised experiment quantifying preferences. In both, participants completed a web-based survey including information about three screening tests (colonoscopy, sigmoidoscopy, and faecal immunochemical testing) and then up to nine scenarios comparing screening to no screening for three levels of baseline risk (1%, 3% and 5% over 15 years) and the three screening tests. Participants reported, after each scenario, whether they would opt for screening (yes/no). Results Of the 20 participants in the think-aloud study 13 did not consider absolute benefits or harms when making decisions concerning CRC screening. In the online experiment (n = 978), 60% expressed intention to attend at 1% risk of CRC, 70% at 3% and 77% at 5%, with no differences between screening tests. At an individual level, 535 (54.7%) would attend at all three risk levels and 178 (18.2%) at none. The 27% whose intention varied by baseline risk were more likely to be younger, without a family history of CRC, and without a prior history of screening. Conclusions Most people in our population were not influenced by the range of absolute benefits and harms associated with CRC screening presented. For an appreciable minority, however, magnitude of benefit was important.
引用
收藏
页数:18
相关论文
共 54 条
  • [1] Women's responses to changes in US preventive task force's mammography screening guidelines: results of focus groups with ethnically diverse women
    Allen, Jennifer D.
    Bluethmann, Shirley Morrison
    Sheets, Margaret
    Opdyke, Kelly Morrison
    Gates-Ferris, Kathryn
    Hurlbert, Marc
    Harden, Elizabeth
    [J]. BMC PUBLIC HEALTH, 2013, 13
  • [2] [Anonymous], Stata Statistical Software
  • [3] Bayne M., 2019, PATIENT EDUC COUNS, DOI [10.1016/j.pec.2019.08.010 31439435, DOI 10.1016/J.PEC.2019.08.01031439435]
  • [4] Comparing 3 Values Clarification Methods for Colorectal Cancer Screening Decision-Making: A Randomized Trial in the US and Australia
    Brenner, Alison
    Howard, Kirsten
    Lewis, Carmen
    Sheridan, Stacey
    Crutchfield, Trisha
    Hawley, Sarah
    Reuland, Dan
    Kistler, Christine
    Pignone, Michael
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 (03) : 507 - 513
  • [5] Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study
    Buskermolen, Maaike
    Cenin, Dayna R.
    Helsingen, Lise M.
    Guyatt, Gordon
    Vandvik, Per Olav
    Haug, Ulrike
    Bretthauer, Michael
    Lansdorp-Vogelaar, Iris
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2019, 367
  • [6] Cancer Research UK, BOW CANC STAT
  • [7] Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing
    Chrysostomou, Andreas C.
    Stylianou, Dora C.
    Constantinidou, Anastasia
    Kostrikis, Leondios G.
    [J]. VIRUSES-BASEL, 2018, 10 (12):
  • [8] A meta-analysis of the effects of presenting treatment benefits in different formats
    Covey, Judith
    [J]. MEDICAL DECISION MAKING, 2007, 27 (05) : 638 - 654
  • [9] Personalised risk communication for informed decision making about taking screening tests
    Edwards, A. G. K.
    Evans, R.
    Dundon, J.
    Haigh, S.
    Hood, K.
    Elwyn, G. J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04):
  • [10] Personalised risk communication for informed decision making about taking screening tests
    Edwards, Adrian G. K.
    Naik, Gurudutt
    Ahmed, Harry
    Elwyn, Glyn J.
    Pickles, Timothy
    Hood, Kerry
    Playle, Rebecca
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (02): : 1 - 96